Spun out from the Mount Sinai Health System, Rx.Health is defining the delivery of Digital Medicine for system-wide transformation. Rx.Health’s first enterprise-wide Digital Medicine curation and prescribing system integrates with electronic health records and enables clinicians to prescribe evidence-based digital navigation programs, digital therapeutics, telemedicine, wearables, and more for rapid outreach, deep engagement and effective monitoring to improve patient outcomes.

- Developing and institutionalizing value proposition and market strategies for digital products and solutions for Healthcare and Life Sciences industries - Collaborating with global business acquisition teams to develop account plans, strategies and unique selling propositions within the Healthcare and Life Sciences core group of offerings - Supporting strategic business plans, business development and marketing initiatives through content creation to build understanding of market needs and drive digital transformation agenda by expressing organization's point of view within and outside the organization

- Managed and delivered solutions through global engagements focused on cost improvement, quality and outcomes improvement, business effectiveness, demand management and clinical benchmarking for commissioning organizations, social care and acute care providers - Business development, thought leadership and management of teams and budgets

- Practice head for research and analysis capability group for global life Sciences, healthcare, government and infrastructure sectors across various service lines and geographies- Managing client relationships and developing business with various global accounts, global lead partners, sector leads and experts, strategy teams and senior executives, providing them with market/industry insights and account research support - Leading and driving high performing team across multiple locations and managing key operational functions including quality assurance, recruitment/hiring, training, performance management, attrition and succession planning- Continued process improvement for standard as well as customized deliverables and developing innovative client-specific knowledge and research programs and products

- Helped the global sector centers and client service teams across various member firms with research solutions like market/competitive intelligence, industry research, company and executive research, market research analysis, and primary research across pharmaceuticals, biotechnology and healthcare sectors

- Full-time equivalent associate for a Wall Street analyst with a leading investment bank, covering biotechnology stocks listed on NASDAQ and NYSE (equity – sell side) - Overseeing wires track and sector watch, providing technical expertise , report writing, thought leadership, database creation and maintenance and other on-demand projects

- Conducted theory and practical courses for undergraduate classes at the University Institute of Pharmaceutical Sciences - Handled a major research project ‘design and development of some new potential calcium channel blockers’ during the PhD course - Designed new potential drug candidates by CADD and QSAR studies, synthesis using novel synthetic techniques and conducting in vivo preclinical studies to identify the promising agents - Published findings in peer reviewed journals and obtained various patents for promising drug candidates

Responsible for the design and synthesis of some new drug molecules on latest therapeutic targets